MARGARET TRUESDELL: Open Payments
NPI 1639695489 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 15 payments from 9 companies in 2025. Trend: 2023 $180 · 2024 $419 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 4 | $312 |
| ABBVIE INC. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Xeomin, VRAYLAR, REXULTI, GEMTESA, MOUNJARO, CAPLYTA, QULIPTA, Ozempic.
Industry payments across NC — which companies pay providers there.
